Sign In
Buy FLDM
$1.83
+0 (+0%)
At Close: Jul 20, 2022
Fluidigm CyTOF Technology Used to Evaluate Stem Cell Therapy as a Potential Treatment for COVID-19 Pneumonia
12:30pm, Thursday, 02'nd Apr 2020
Fluidigm Corporation (FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Fluidigm® CyTOF® technology was used
Dublin, April 02, 2020 -- The "Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application, Region, and Competitive Landscape - Analysis and.
Single Cell Sequencing Industry, Forecast to 2029: Expected to Grow at a Significant CAGR of 15.24%
01:45pm, Wednesday, 01'st Apr 2020
The "Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2018-2029" report h
The "Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2018-2029" report h
Dublin, March 30, 2020 -- The "Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive.
Bank of Montreal Can Cuts Holdings in Fluidigm Co. (NASDAQ:FLDM)
09:58am, Monday, 30'th Mar 2020
Bank of Montreal Can reduced its position in Fluidigm Co. (NASDAQ:FLDM) by 44.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 8,780 shares of the medical research
Prudential Financial Inc. Invests $108,000 in Fluidigm Co. (NASDAQ:FLDM)
11:00am, Saturday, 28'th Mar 2020
Prudential Financial Inc. bought a new stake in Fluidigm Co. (NASDAQ:FLDM) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bo
Global Single Cell Sequencing Market to Grow at a CAGR of 15.24% from 2019-2029
The RNA sequencing industry analysis projects the market to grow at a significant CAGR of 14.21% during the forecast period, 2019-2028
08:53am, Thursday, 26'th Mar 2020
New York, March 26, 2020 -- Reportlinker.com announces the release of the report "Global RNA Sequencing Market: Focus on Product, Technology, Workflow, End User, Application,.
Mar 23, 2020 (The Expresswire) --
Final Report will add the analysis of the impact of COVID-19 on this industry Global “Analytical Instruments for Drug...
Alyeska Investment Group L.P. Takes $3.91 Million Position in Fluidigm Co. (NASDAQ:FLDM)
09:52am, Friday, 20'th Mar 2020
Alyeska Investment Group L.P. purchased a new stake in shares of Fluidigm Co. (NASDAQ:FLDM) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional i
Brokerages Anticipate Fluidigm Co. (NASDAQ:FLDM) to Announce -$0.11 EPS
09:12am, Friday, 20'th Mar 2020
Analysts expect Fluidigm Co. (NASDAQ:FLDM) to report ($0.11) earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have issued estimates for Fluidigm’s earnings, with
Zacks: Analysts Expect Fluidigm Co. (NASDAQ:FLDM) Will Announce Quarterly Sales of $29.22 Million
06:30am, Thursday, 19'th Mar 2020
Wall Street analysts predict that Fluidigm Co. (NASDAQ:FLDM) will post sales of $29.22 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Fluidigm’s
Fluidigm says consortium of medical schools utilizing microfluidics technology FLDM
01:25pm, Monday, 16'th Mar 2020
Fluidigm says consortium of medical schools utilizing microfluidics technology FLDM
Fluidigm Corp:
